S 3092
116th Congress
Senate
Health
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Intellectual property
Prescription drugs
Expanding Access to Low-Cost Generics Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 18, 2019
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Expanding Access to Low-Cost Generics Act of 2019
This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 3092: Expanding Access to Low-Cost Generics Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-3092/
"S. 3092: Expanding Access to Low-Cost Generics Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3092/.
S. 3092, 116th Cong. (2026), https://openamerica.io/bill/116-S-3092/.
[S. 3092: Expanding Access to Low-Cost Generics Act of 2019](https://openamerica.io/bill/116-S-3092/)